• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CONSTELLATION VISION SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number LXT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Endophthalmitis (1835); Loss of Vision (2139); Vitrectomy (2643)
Event Date 04/14/2019
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A surgeon reported a patient had "vision disappear" and was diagnosed with acute suppurative endophthalmitis four days postoperatively in the left eye following a 25 gauge vitrectomy, retinal laser treatment and membrane peel procedure.A vitreous puncture sampling, injection, anterior chamber puncture and a vitreous cavity lavage was performed in the emergency department.Staphylococcus lugdunensis bacteria was cultured and treated with intravenous antibiotic and anti-inflammatory agent.The inflammation was controlled and the vision is gradually improving.
 
Manufacturer Narrative
No probe or trocar samples have been returned for evaluation.Photo attached to the parent complaint was reviewed by the manufacturing site.Photo shows a pouch with a small part tray with three trocar assembly and the label confirms the reported product and lot numbers.A review of the device history record traceable to the reported lot number indicates that the product was processed and released according to the product¿s acceptance criteria.A complaint history examination indicates there are no additional complaints associated with the lot for the reported probe or trocar issues.No samples were returned and the device history record reviews of the lot number provided indicated the probe and trocar products were processed and released according to the product¿s acceptable criteria, therefore, the root cause for the customer complaint issues cannot be determined.The exact root cause for this complaint is unknown as no sample was returned; therefore, specific action with regards to this complaint cannot be taken.All probes are 100% visually inspected and tested for actuation, aspiration, and cut during manufacturing.An acceptance quality inspection is performed to ensure trocar product meets release acceptance criteria.Any non-conformances found are removed from the lot and scrapped.No additional action is required at this time.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSTELLATION VISION SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
MDR Report Key8611897
MDR Text Key145133925
Report Number2028159-2019-00879
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
PMA/PMN Number
K101285
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 08/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberLXT
Device Catalogue Number8065751550
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/29/2019
Initial Date FDA Received05/15/2019
Supplement Dates Manufacturer Received07/25/2019
Supplement Dates FDA Received08/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ADRENALINE HYDROCHLORIDE; BALANCED SALT SOLUTON; CONSTELLATION ULTRAVIT PROBE; EDGEPLUS VALVED ENTRY SYSTEM; ADRENALINE HYDROCHLORIDE; BALANCED SALT SOLUTON; CONSTELLATION ULTRAVIT PROBE; EDGEPLUS VALVED ENTRY SYSTEM
Patient Outcome(s) Other;
Patient Age60 YR
-
-